- Full Text
- Scholarly Journal
INTRA- AND INTER-SUBJECT VARIABILITY FOR INCREASES IN PLASMA KETONE BODIES IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH THE SGLT2 INHIBITOR CANAGLIFLOZIN
Endocrine Practice; Jacksonville Vol. 23, Iss. 1, (Jan 2017): 41A,42A.